Fear, anxiety, stress, and burnout can all happen to parents of children with sickle cell disease, writes columnist.

Disc Medicine is planning to launch a trial by year's end to test DISC-3405, its treatment candidate for iron overload, in ...

Invisible Disabilities Week may have passed by unnoticed, but many of us live it every day, writes columnist Mary Shaniqua.

Wilson writes that withdrawing has been for him a way to feel safe, but frustrated his ability to connect to others.

Testing for PlGF levels can predict the risk of early-onset preeclampsia during pregnancy in people with sickle cell disease, ...

Tocilizumab was effectively used off-label in four young adults with sickle cell disease (SCD) to treat hyperhemolysis ...

Columnist Mary Shaniqua offers up ideas for managing sickle cell disease to get the most out of busy end-of-year events.

The European Medicines Agency (EMA) has confirmed the continuing suspension of marketing authorization for Pfizer’s sickle cell disease (SCD) treatment Oxbryta (voxelotor) — withdrawn from the market ...

How quickly time flies! I can hardly believe I’ve nearly completed another trip around the sun. It feels like only yesterday I was penning my thoughts for my 38th birthday column. I’m overwhelmed with ...

In the fall of my sophomore year of high school, my hematologist recommended me for my pediatric sickle cell program’s teen clinic. At that point, I was going to the doctor every one to three months, ...

People with sickle cell disease (SCD) seeking emergency care for vaso-occlusive crises (VOCs) are often not triaged appropriately, leading to unnecessarily long waits for pain relief. A recent study ...